Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04569253 · ClinicalTrials.gov registry record · NA
Multi-Center Pivotal Study of Radiofrequency Device
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT04569253: Completed NA study, sponsored by Cynosure.
NCT04569253 is a NA study that has completed, run by Cynosure. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04569253, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
This is a prospective, controlled, multi-center study. Patients will be enrolled and treated with a radiofrequency device in this study if they have unwanted fat in the flank (love handle) area.
Primary Outcome
Correct identification of pre-treatment images vs. the 12-week follow up images by blinded evaluators.
Interventions
- DEVICE TempSure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2020-07-28 |
| Est. Completion | 2021-03-26 |
| Phase | NA |
What the finished NCT04569253 record still lists
NCT04569253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which TempSure is the first listed.
NCT04569253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04569253 about?
NCT04569253 is a clinical study titled "Multi-Center Pivotal Study of Radiofrequency Device". This is a prospective, controlled, multi-center study. Patients will be enrolled and treated with a radiofrequency device in this study if they have unwanted fat in the flank (love handle) area.
What is the current status of trial NCT04569253?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2020-07-28. Estimated completion is 2021-03-26.
What interventions are being tested in trial NCT04569253?
The interventions under investigation include: TempSure (DEVICE).
Who is sponsoring clinical trial NCT04569253?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04569253's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI